1. Academic Validation
  2. Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells

Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells

  • Oncotarget. 2016 May 10;7(19):27176-84. doi: 10.18632/oncotarget.8401.
Guang Chen 1 2 Jin-Ye Xu 3 4 Jie Chen 5 Jian-Xin Zhang 5 Jun Zhou 5 Yong Liang 4 5 Xiao-Fei Ding 5
Affiliations

Affiliations

  • 1 School of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou, Zhejiang, China.
  • 2 Institute of Tumor, Taizhou University, Taizhou, Zhejiang, China.
  • 3 Laboratory of Cancer Biology, Provincial Key Lab of Biotherapy in Zhejiang, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China.
  • 4 Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
  • 5 School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Abstract

PIG3 is a target of the tumor suppressor p53 and is thought to be involved in p53-mediated cell Apoptosis. Although PIG3 is similar to oxidoreductases involved in generating ROS, whether PIG3 would regulate HIF-1α was never characterized directly. Here we demonstrated that knockdown of PIG3 by transfecting with specific siRNA could increase the expression of HIF-1α in several human Cancer cell lines, including CAKI, FTC-133 and A549. It indicates that PIG3 may be involved in the regulation of HIF-1α. Furthermore, we revealed that PIG3-siliencing increased HIF-1α protein level through promoting its protein biosynthesis via mTOR pathway. In addition, the effect of PIG3 on the production of HIF-1α was further related to VEGF secretion and cell migration. PIG3-downregulation increased the secretion of VEGF and promoted the migration of renal Cancer cells obviously. Taken together, these data suggest that PIG3 was involved in HIF-1α regulation, and reveal a novel signaling pathway of PIG3/HIF-1α in the regulation of cell migration in renal cell carcinoma.

Keywords

HIF-1α; PIG3; mTOR; migration; renal cell carcinoma.

Figures
Products